Synthesis, structure and biological activity of 1,2,4-triazolo-1,3-thiazine derivatives. 1992

H Foks, and W Rudnicka, and M Głowka, and R Kaliszan, and A Nasal, and B Damasiewicz, and A Radwańska, and J Petrusewicz, and H Trzeciak, and B Okopień
Department of Organic Chemistry, Medical Academy of Gdańsk, Poland.

A group of condensed triazole-thiazine derivatives (2a-i, 3b, 3j) was obtained in reaction of the corresponding 5-substituted 1,2,4-triazole-3-thiones (1a-j) with epichlorohydrin in alkaline medium. The structure of the compounds synthesized was confirmed by spectral and roentgenographic methods. Tuberculostatic and circulatory activities of the compounds were also studied.

UI MeSH Term Description Entries
D008297 Male Males
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D002317 Cardiovascular Agents Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. Cardioactive Agent,Cardioactive Drug,Cardiovascular Agent,Cardiovascular Drug,Cardioactive Agents,Cardioactive Drugs,Cardiovascular Drugs,Agent, Cardioactive,Agent, Cardiovascular,Drug, Cardioactive,Drug, Cardiovascular
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013843 Thiazines
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole

Related Publications

H Foks, and W Rudnicka, and M Głowka, and R Kaliszan, and A Nasal, and B Damasiewicz, and A Radwańska, and J Petrusewicz, and H Trzeciak, and B Okopień
February 2011, European journal of medicinal chemistry,
H Foks, and W Rudnicka, and M Głowka, and R Kaliszan, and A Nasal, and B Damasiewicz, and A Radwańska, and J Petrusewicz, and H Trzeciak, and B Okopień
February 2002, Farmaco (Societa chimica italiana : 1989),
H Foks, and W Rudnicka, and M Głowka, and R Kaliszan, and A Nasal, and B Damasiewicz, and A Radwańska, and J Petrusewicz, and H Trzeciak, and B Okopień
January 1991, Farmaco (Societa chimica italiana : 1989),
H Foks, and W Rudnicka, and M Głowka, and R Kaliszan, and A Nasal, and B Damasiewicz, and A Radwańska, and J Petrusewicz, and H Trzeciak, and B Okopień
January 2003, Acta poloniae pharmaceutica,
H Foks, and W Rudnicka, and M Głowka, and R Kaliszan, and A Nasal, and B Damasiewicz, and A Radwańska, and J Petrusewicz, and H Trzeciak, and B Okopień
January 1997, Die Pharmazie,
H Foks, and W Rudnicka, and M Głowka, and R Kaliszan, and A Nasal, and B Damasiewicz, and A Radwańska, and J Petrusewicz, and H Trzeciak, and B Okopień
January 2018, Medicinal chemistry (Shariqah (United Arab Emirates)),
H Foks, and W Rudnicka, and M Głowka, and R Kaliszan, and A Nasal, and B Damasiewicz, and A Radwańska, and J Petrusewicz, and H Trzeciak, and B Okopień
April 2020, Scientific reports,
H Foks, and W Rudnicka, and M Głowka, and R Kaliszan, and A Nasal, and B Damasiewicz, and A Radwańska, and J Petrusewicz, and H Trzeciak, and B Okopień
August 2008, Bioorganic & medicinal chemistry,
H Foks, and W Rudnicka, and M Głowka, and R Kaliszan, and A Nasal, and B Damasiewicz, and A Radwańska, and J Petrusewicz, and H Trzeciak, and B Okopień
November 1995, Die Pharmazie,
H Foks, and W Rudnicka, and M Głowka, and R Kaliszan, and A Nasal, and B Damasiewicz, and A Radwańska, and J Petrusewicz, and H Trzeciak, and B Okopień
March 2008, Archives of pharmacal research,
Copied contents to your clipboard!